A detailed history of Congress Asset Management CO transactions in Vericel Corp stock. As of the latest transaction made, Congress Asset Management CO holds 836,481 shares of VCEL stock, worth $39.3 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
836,481
Previous 137,334 509.09%
Holding current value
$39.3 Million
Previous $4.89 Million 789.84%
% of portfolio
0.32%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$32.52 - $52.33 $22.7 Million - $36.6 Million
699,147 Added 509.09%
836,481 $43.5 Million
Q4 2023

Mar 04, 2024

BUY
$30.85 - $37.09 $510,876 - $614,210
16,560 Added 13.71%
137,334 $4.89 Million
Q3 2023

Nov 01, 2023

BUY
$31.69 - $39.25 $3.83 Million - $4.74 Million
120,774 New
120,774 $4.05 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.21B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.